135 related articles for article (PubMed ID: 32586936)
1. OCT changes in peri-tumour normal retina following ruthenium-106 and proton beam radiotherapy for uveal melanoma.
Hussain R; Heussen FM; Heimann H
Br J Ophthalmol; 2021 May; 105(5):648-652. PubMed ID: 32586936
[TBL] [Abstract][Full Text] [Related]
2. Blue-Light Fundus Autofluorescence Imaging following Ruthenium-106 Brachytherapy for Choroidal Melanoma.
Bindewald-Wittich A; Swenshon T; Carasco E; Dreyhaupt J; Willerding GD
Ophthalmologica; 2020; 243(4):303-315. PubMed ID: 31940652
[TBL] [Abstract][Full Text] [Related]
3. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium-106 plaque brachytherapy for uveal melanoma.
Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography angiography-based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy.
Shanmugam PM; Konana VK; Ramanjulu R; Mishra KCD; Sagar P; Kumar D
Indian J Ophthalmol; 2019 Dec; 67(12):2086-2088. PubMed ID: 31755470
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
9. Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.
Marconi DG; de Castro DG; Rebouças LM; Bernardes Gil GO; Fogaroli RC; Conte Maia MA; Gobo Silva ML; Assis Pellizzon AC; Motono Chojniak MM
Brachytherapy; 2013; 12(3):235-9. PubMed ID: 22436517
[TBL] [Abstract][Full Text] [Related]
10. Plaque radiotherapy for the management of uveal metastasis.
Shields CL; Shields JA; De Potter P; Quaranta M; Freire J; Brady LW; Barrett J
Arch Ophthalmol; 1997 Feb; 115(2):203-9. PubMed ID: 9046255
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of vascular changes with optical coherence tomography angiography after ruthenium-106 brachytherapy of circumscribed choroidal hemangioma.
Cennamo G; Rossi C; Breve MA; Velotti N; Farella A; Liuzzi R; Cennamo G
Eye (Lond); 2018 Aug; 32(8):1401-1405. PubMed ID: 29773881
[TBL] [Abstract][Full Text] [Related]
12. Long-term visual outcomes after ruthenium plaque brachytherapy for posterior choroidal melanoma.
O'Day RFJ; Roelofs KA; Negretti GS; Hay G; Arora AK; Stoker I; Damato BE; Sagoo MS; Cohen VML
Eye (Lond); 2023 Apr; 37(5):959-965. PubMed ID: 35140328
[TBL] [Abstract][Full Text] [Related]
13. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
15. Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.
Russo A; Laguardia M; Damato B
Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1533-40. PubMed ID: 22354369
[TBL] [Abstract][Full Text] [Related]
16. AVATAR: Analysis for Visual Acuity Prediction After Eye Interventional Radiotherapy.
Pagliara MM; Tagliaferri L; Lenkowicz J; Azario L; Giattini D; Fionda B; Sammarco MG; Lancellotta V; Gambacorta MA; Blasi MA
In Vivo; 2020; 34(1):381-387. PubMed ID: 31882502
[TBL] [Abstract][Full Text] [Related]
17. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
[TBL] [Abstract][Full Text] [Related]
18. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
19. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy.
Kubicka-Trząska A; Karska-Basta I; Oleksy P; Romanowska-Dixon B
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2015-9. PubMed ID: 26004077
[TBL] [Abstract][Full Text] [Related]
20. Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus.
Shields CL; Kaliki S; Rojanaporn D; Ferenczy SR; Shields JA
Arch Ophthalmol; 2012 Jul; 130(7):850-6. PubMed ID: 22776921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
